Last reviewed · How we verify

NCT06815445: TKA

Postoperative Pain and Blood Loss of Non-use Compared to Partial-use of a Tourniquet in Bilateral Total Knee Replacement

Completed NA Last updated 13 June 2025
What this trial tests

NA trial testing None tourniquet in Pain, Postoperative in 20 participants. Completed in 30 October 2024.

Timeline
1 November 2022
Primary endpoint
1 August 2024
30 October 2024

Quick facts

Lead sponsorQueen Savang Vadhana Memorial Hospital, Thailand
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 November 2022
Primary completion1 August 2024
Estimated completion30 October 2024
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Queen Savang Vadhana Memorial Hospital, Thailand

Who can join

50 and older, any sex, with Pain, Postoperative or Total Knee Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative pain and blood loss of non-use compared to partial-use of a tourniquet in bilateral total knee replacement: A Randomized- Control Trial This study aimed to compare the effects of non-use (NTU) and partial-use (before osteotomy to skin closure; BOO) of a tourniquet in bilateral total knee arthroplasty (TKA) on postoperative pain and complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Queen Savang Vadhana Memorial Hospital, Thailand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06815445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing